Literature DB >> 16622688

Total-body MR-imaging in oncology.

Juergen F Schaefer1, Heinz-Peter W Schlemmer.   

Abstract

Although MRI is an effective modality in oncology, state-of-the-art total-body MRI (TB-MRI) in the past was infeasible in the diagnostic work-up, due to the need for repeated examinations with repositioning and separate surface coils to cover all body parts. To overcome this limitation, either a moving table platform in combination with the body-coil or a special designed rolling table platform with one body phased-array coil have been implemented with promising results for both tumor staging and metastases screening. Since 2004, state-of-the-art TB-MR imaging with high spatial resolution has become feasible using a newly developed 1.5 Tesla TB-MRI system with multiple receiver channels. This review gives an overview based on the recent literature as well as our own experience concerning the possibilities, challenges, and limitations of TB-MRI in oncology, emphasizing both oncological staging and early tumor detection in asymptomatic subjects.

Entities:  

Mesh:

Year:  2006        PMID: 16622688     DOI: 10.1007/s00330-006-0199-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  79 in total

Review 1.  Whole-body MR imaging. Practical issues, clinical applications, and future directions.

Authors:  S J Eustace; R Walker; M Blake; E K Yucel
Journal:  Magn Reson Imaging Clin N Am       Date:  1999-05       Impact factor: 2.266

Review 2.  Fast magnetic resonance imaging techniques.

Authors:  Q Chen; K W Stock; P V Prasad; H Hatabu
Journal:  Eur J Radiol       Date:  1999-02       Impact factor: 3.528

3.  [Whole-body MRA on a rolling table platform (AngioSURF)].

Authors:  S G Ruehm; M Goyen; H H Quick; M Schlepütz; H Schlepütz; S Bosk; J Barkhausen; M E Ladd; J F Debatin
Journal:  Rofo       Date:  2000-08

4.  Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.

Authors:  Masami Iizuka-Mikami; Kiyohisa Nagai; Koji Yoshida; Takashi Sugihara; Yoshimasa Suetsugu; Makoto Mikami; Tsutomu Tamada; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Eur Radiol       Date:  2004-02-18       Impact factor: 5.315

5.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Authors:  H E Daldrup-Link; C Franzius; T M Link; D Laukamp; J Sciuk; H Jürgens; O Schober; E J Rummeny
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

6.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Authors:  J K Gohagan; P C Prorok; R B Hayes; B S Kramer
Journal:  Control Clin Trials       Date:  2000-12

7.  Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.

Authors:  John K Gohagan; Pamela M Marcus; Richard M Fagerstrom; Paul F Pinsky; Barnett S Kramer; Philip C Prorok; Susan Ascher; William Bailey; Brenda Brewer; Timothy Church; Deborah Engelhard; Melissa Ford; Mona Fouad; Matthew Freedman; Edward Gelmann; David Gierada; William Hocking; Subbarao Inampudi; Brian Irons; Christine Cole Johnson; Arthur Jones; Gena Kucera; Paul Kvale; Karen Lappe; William Manor; Alisha Moore; Hrudaya Nath; Sarah Neff; Martin Oken; Michael Plunkett; Helen Price; Douglas Reding; Thomas Riley; Martin Schwartz; David Spizarny; Roberta Yoffie; Carl Zylak
Journal:  Lung Cancer       Date:  2005-01       Impact factor: 5.705

8.  Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.

Authors:  John Gohagan; Pamela Marcus; Richard Fagerstrom; Paul Pinsky; Barnett Kramer; Philip Prorok
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

9.  Whole-body MRI using a rolling table platform for the detection of bone metastases.

Authors:  Thomas C Lauenstein; Lutz S Freudenberg; Susanne C Goehde; Stefan G Ruehm; Mathias Goyen; Silke Bosk; Jörg F Debatin; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2002-03-08       Impact factor: 5.315

Review 10.  Fast STIR whole-body MR imaging in children.

Authors:  Christian J Kellenberger; Monica Epelman; Stephen F Miller; Paul S Babyn
Journal:  Radiographics       Date:  2004 Sep-Oct       Impact factor: 5.333

View more
  11 in total

1.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

2.  Efficient whole-body MRI interpretation: evaluation of a dedicated software prototype.

Authors:  Patrick Asbach; Valer Canda; Kay-Geert A Hermann; Lasse Krug; Horst K Hahn; Bernd Hamm; Christian Klessen
Journal:  J Digit Imaging       Date:  2008-02-12       Impact factor: 4.056

3.  Broadening the scope of image-guided radiotherapy (IGRT).

Authors:  Carlo Greco; C Clifton Ling
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

4.  Comparison of a new whole-body continuous-table-movement protocol versus a standard whole-body MR protocol for the assessment of multiple myeloma.

Authors:  S Weckbach; H J Michaely; A Stemmer; S O Schoenberg; D J Dinter
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

5.  Assessment of chemotherapy response in non-Hodgkin lymphoma involving the neck utilizing diffusion kurtosis imaging: a preliminary study.

Authors:  Rui Wu; Shi Teng Suo; Lian Ming Wu; Qiu Ying Yao; Hong Xia Gong; Jian Rong Xu
Journal:  Diagn Interv Radiol       Date:  2017 May-Jun       Impact factor: 2.630

Review 6.  Detection of recurrent rectal cancer with CT, MRI and PET/CT.

Authors:  O Schaefer; M Langer
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 7.034

Review 7.  Whole-body magnetic resonance imaging in children: state of the art.

Authors:  Sara Reis Teixeira; Jorge Elias Junior; Marcello Henrique Nogueira-Barbosa; Marcos Duarte Guimarães; Edson Marchiori; Marcel Koenigkam Santos
Journal:  Radiol Bras       Date:  2015 Mar-Apr

8.  Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.

Authors:  C Schraml; N F Schwenzer; O Sperling; P Aschoff; M P Lichy; M Müller; C Brendle; M K Werner; C D Claussen; C Pfannenberg
Journal:  Cancer Imaging       Date:  2013-03-05       Impact factor: 3.909

9.  Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?

Authors:  Dong Hoon Lee; Jong Kil Nam; Hee Suk Jung; Seong Jang Kim; Moon Kee Chung; Sung-Woo Park
Journal:  Investig Clin Urol       Date:  2017-08-03

10.  Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the Oncology Task Force of the ESPR.

Authors:  Jürgen F Schäfer; Claudio Granata; Thekla von Kalle; Martin Kyncl; Annemieke S Littooij; Pier Luigi Di Paolo; Irmina Sefic Pasic; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.